shot

Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed mRESVIA, its vaccine targeted at the respiratory syncytial virus (RSV). Issuing a so-called positive opinion, EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended grantingContinue Reading

MarsBars/E+ via Getty Images Novavax (NASDAQ:NVAX) has submitted an application to the European Medicines Agency seeking authorization of its JN.1 COVID-19 vaccine to be administered starting in the fall. The shot is also effective against the KP.2 and KP.3 variants, which alone account for nearly 54% of the cases currentlyContinue Reading